Hypoparathyroidism Natural History Study

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT05793853
Status
Recruiting
Apply to this trial

Conditions

  • Hypoparathyroidism

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Accepted

Study Details

This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. The study objectives are to: 1. Build a prospective cohort of patients to study HPT-associated end-organ damage. 2. Determine end-organ physiologic consequences of HPT. 3. Elucidate determinants of HPT-associated end-organ damage. Funding Source - FDA OOPD

Key Dates

Start date
Aug 25, 2022
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
106 participants (estimated)

Arms

  • Arm: Hypoparathyroidism Subjects
    Patients who have the disease hypoparathyroidism, who are being followed to monitor various aspects of the disease over time. No interventions.
  • Arm: Control Subjects
    Healthy individuals to be followed to compare to hypoparathyroidism patients

Primary Outcome Measure

Kidney function [ Time Frame: baseline, 6, 12, 18, 24, 30, 36 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Medical Center - Harkness PavillionNew YorkNew York10032
Noelle Texeira
[email protected]
212-305-2801
Mishaela Rubin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Columbia University Medical Center - Harkness Pavillion· New York, NY

Related Studies